RTS Life Science has partnered with Hall Analytical Laboratories to provide analytical services and consultancy in the area of automation and inhaler testing.
Initially focussed on inhaled drug delivery devices, the two companies will share facilities, technology and resources to provide a range of services to help organisations improve efficiency in the development, adoption and use of automation.
The services will combine RTS Life Science's device testing expertise and automated inhaler testing technology with Hall Analytical Laboratories' analytical problem solving expertise and GXP-accredited facilities.
Services to be provided in consultation with clients include: method development for both manual and automated applications; equipment and analytical validation services; performance qualification of automation systems; laboratory and analytical consultancy for OINDP products; canister content testing; plus emitted and delivered dose uniformity testing.
Mark Fish, director of drug delivery automation for RTS Life Science, said: 'Our experience of inhaler testing automation means we understand how devices work and appreciate factors that can introduce variability in analytical testing.
'In addition, we have proven experience validating automation systems in accordance with the latest regulatory guidance.
'By offering these services, customers will benefit from this knowledge and have new options to help improve laboratory efficiency,' he added.
'This partnership with RTS allows us to offer a more comprehensive range of services for inhaled devices, building on our experience working with pharmaceutical clients and our reputation for regulatory compliance and analytical problem solving,' said Malcolm Kimber, managing director of Hall Analytical Laboratories.
